Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review

Heart failure (HF) continues to increase in prevalence, representing a significant burden to healthcare systems in the USA. Despite several established HF therapies, particularly for HF with reduced ejection fraction (HFrEF), rates of HF hospitalizations and cardiovascular (CV) mortality remain very...

Descripción completa

Detalles Bibliográficos
Autor principal: Jhalani, Nisha B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309138/
https://www.ncbi.nlm.nih.gov/pubmed/35699903
http://dx.doi.org/10.1007/s12325-022-02169-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309138/
https://www.ncbi.nlm.nih.gov/pubmed/35699903
http://dx.doi.org/10.1007/s12325-022-02169-3

Ejemplares similares